Your session is about to expire
Daytrana vs Adderall
Introduction
For patients with Attention-Deficit/Hyperactivity Disorder (ADHD) or similar conditions, certain drugs that modulate the levels of neurotransmitters in the brain can be beneficial in managing symptoms and improving focus. Daytrana and Adderall are two such medications frequently prescribed for these purposes. Both impact certain neurotransmitters but do so differently.
Daytrana is a methylphenidate transdermal system; it's essentially a patch you stick on your skin which then delivers medication throughout the day, affecting dopamine levels. On the other hand, Adderall is classified as an amphetamine type stimulant which also affects dopamine but additionally impacts norepinephrine too.
While both have proven effective at helping manage ADHD symptoms, their modes of delivery differ significantly: one being a daily oral pill (Adderall), while the other is a patch applied to the skin (Daytrana). This difference may make one more suitable than another depending on individual patient needs.
Daytrana vs Adderall Side By Side
| Attribute | Daytrana | Adderall |
|---|---|---|
| Brand Name | Daytrana | Adderall |
| Contraindications | Cannot be taken if you are taking, or have recently been taking monoamine oxidase (MAO) inhibitors. | Cannot be taken if you are taking, or have recently been taking monoamine oxidase (MAO) inhibitors. |
| Cost | A one-month supply (30 patches) of Daytrana (20 mg) averages around $370, which works out to about $12.33/day. | The price for 60 tablets of Adderall XR (20 mg) is approximately $400, equating to roughly $6.67/day. |
| Generic Name | Methylphenidate transdermal system | Amphetamine salts ER |
| Most Serious Side Effect | Neurological reaction - rigidity in muscles accompanied by fever and confusion | Heart problems: chest pain, trouble breathing, feeling like you might pass out |
| Severe Drug Interactions | MAO inhibitors | MAO inhibitors |
| Typical Dose | Starts at 10 mg/day for children and adolescents aged 6-17 years old, up to a maximum dose of 30 mg/day. | Begins at a dose of 5-10 mg/day for children, up to 20-30 mg/day. For adults, typically 20 mg/day, up to a maximum of around 60mg. |
What is Daytrana?
Methylphenidate (the active ingredient in Daytrana) is a stimulant drug primarily used to treat attention deficit hyperactivity disorder (ADHD). It was first approved by the FDA for this use in 2006. Daytrana, distinctive due to its patch delivery system, works by increasing levels of dopamine and norepinephrine between synapses in the brain. This medication is typically prescribed for children aged six years and older who have been diagnosed with ADHD. While it does influence serotonin levels to an extent, its primary focus is on altering dopamine and norepinephrine pathways.
On the other hand, Adderall contains mixed amphetamine salts and acts as a powerful stimulant impacting both dopamine and norepinephrine neurotransmitters. Approved by the FDA much earlier than Daytrana - in 1996 - Adderall has been widely used for treating ADHD symptoms as well as narcolepsy.
Although both medications can effectively manage ADHD symptoms, they differ significantly regarding their side effects profile, dosage forms available, and length of action.
What conditions is Daytrana approved to treat?
Daytrana and Adderall are both approved for the treatment of Attention Deficit Hyperactivity Disorder (ADHD):
- Daytrana, a patch applied to the skin, is used in patients aged 6 years and older as part of a total treatment program that may include psychological, educational, and social interventions.
- Adderall is an oral medication used for treating ADHD not only in children aged six years or older but also in adults as part of comprehensive treatment strategies that can include counseling or other therapies. It's also indicated for narcolepsy.
How does Daytrana help with these illnesses?
Daytrana helps to manage attention deficit hyperactivity disorder (ADHD) by increasing the amount of dopamine and norepinephrine available in the synapses of the brain. It does this by inhibiting their reabsorption into the neurons, so levels can be maintained higher for longer periods of time. Both dopamine and norepinephrine are neurotransmitters, chemicals that act as messengers in the brain and throughout the body, that play an important role in attention, memory, mood, motivation among other functions. In individuals with ADHD it is thought there may be relatively lower levels or activity of these neurotransmitters. Therefore, by increasing dopamine and norepinephrine availability Daytrana can limit symptoms associated with ADHD - such as impulsivity and difficulty focusing - helping patients manage their condition more effectively.
What is Adderall?
Adderall, a brand name for a combination of amphetamine salts, is primarily used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. This central nervous system stimulant increases the levels of dopamine and norepinephrine in the brain by reducing their reabsorption, similar to bupropion. It also has an effect on serotonin but unlike SSRI antidepressants, it does not inhibit its reuptake. First approved by the FDA in 1996, Adderall's action on these neurotransmitters comes with a distinct side-effect profile: while it can cause insomnia and loss of appetite rather than sedation or weight gain often associated with SSRIs like Prozac, misuse can lead to serious cardiovascular events and psychological dependence. Nonetheless, the stimulating effects on dopamine and norepinephrine have proven beneficial for patients struggling with ADHD who do not respond well to different treatment options such as Daytrana.
What conditions is Adderall approved to treat?
Adderall is approved for the treatment of:
- Attention Deficit Hyperactivity Disorder (ADHD)
- Narcolepsy, a sleep disorder characterized by excessive daytime sleepiness and sudden attacks of sleep
This drug acts as a central nervous system stimulant, helping to increase attention span and decrease impulsivity and hyperactive behavior in those with ADHD.
How does Adderall help with these illnesses?
Adderall is a powerful stimulant that increases the levels of dopamine and norepinephrine in the brain, thereby enhancing focus, attention, and energy levels. Its role in regulating dopamine – a neurotransmitter associated with pleasure and reward – is heavily involved in managing symptoms of Attention Deficit Hyperactivity Disorder (ADHD). Adderall's ability to boost norepinephrine levels aids wakefulness and concentration, making it an effective treatment for ADHD. Unlike Daytrana which is delivered through a skin patch, Adderall comes as an oral medication. Although both drugs are used to treat ADHD, they differ significantly in their delivery mechanism; while Daytrana releases medication steadily over several hours via transdermal absorption, Adderall starts working faster but may require more frequent dosing throughout the day due to its shorter half-life.
How effective are both Daytrana and Adderall?
Both Daytrana and Adderall have a proven track record in treating patients with ADHD, approved by the FDA in 2006 and 1996 respectively. These two medications function through different mechanisms, hence they may be recommended under varying circumstances. Daytrana is a methylphenidate transdermal system patch that provides continuous delivery of medication throughout the day, while Adderall contains amphetamine salts that are taken orally.
The efficacy of both drugs has been extensively studied with results suggesting comparable effectiveness in managing symptoms of ADHD. A study conducted in 2014 comparing methylphenidate (the active ingredient in Daytrana) to mixed amphetamine salts (found in Adderall), showed no significant difference between the two treatments regarding their abilities to manage ADHD symptoms.
Daytrana's unique delivery method allows for extended release over several hours, which can offer more consistent symptom management compared to oral medications like Adderall. However, skin irritations at the site of application are a common side effect of using Daytrana patches. On the other hand, Adderall has an established history as an effective treatment option for people with ADHD but its use may lead to physical dependence or addiction due to its composition.
A meta-analysis published in 2007 indicated that while both drugs were significantly more effective than placebo at reducing symptoms associated with ADHD, long-term safety profiles suggest caution when prescribing these stimulants especially among patients who have pre-existing heart conditions or anxiety disorders.
In conclusion, although both drugs have similar efficacy rates and side effects profiles such as increased heart rate and decreased appetite; they vary greatly on their administration methods - one being a patch applied on skin (Daytrana) versus one taken orally (Adderall). Hence it is important for healthcare providers and patients alike to consider individual preferences along with potential risks before deciding on either treatment plan.
Find Top Clinical Trials
Choose from over 30,000 active clinical trials.
At what dose is Daytrana typically prescribed?
Dosages of Daytrana, a transdermal patch for ADHD, start at 10 mg/day for children and adolescents aged 6-17 years old. If there is no response after two weeks, the dosage can be increased in increments of 10 mg every week up to a maximum dose of 30 mg/day. Adderall dosing starts at 5mg once or twice daily and may be increased by your doctor in increments of 5mg weekly as needed. The recommended maximum daily dose for children is generally around 30mg, although this could vary based on individual needs and responses. In both medications, it's essential not to exceed the prescribed dosage without consulting your healthcare provider.
At what dose is Adderall typically prescribed?
Adderall treatment usually begins at a dose of 5-10 mg/day for children and can be gradually increased to 20-30 mg/day, divided into two doses, taken 4-6 hours apart. For adults who are starting Adderall therapy, the initial dosage is typically 20 mg/day. The total daily dose may be increased in increments of 5 or 10 mg at weekly intervals until an optimal response is obtained. The maximum recommended daily dose for adults with ADHD is usually around 40 mg but may go up to approximately 60mg if there's no adequate response to lower dosages after appropriate adjustments over time.
What are the most common side effects for Daytrana?
Notable side effects that may be associated with Daytrana include:
- Decreased appetite
- Trouble sleeping (insomnia)
- Nausea and vomiting
- Abdominal pain
- Weight loss
- Nervousness, anxiety
- Increased blood pressure and heart rate
- Tics or Tourette’s syndrome
- Slowed growth in children
This is not a comprehensive list of all possible side effects. If any of these symptoms persist or worsen, it's important to consult your healthcare provider immediately.
Are there any potential serious side effects for Daytrana?
Daytrana, like Adderall, has the potential for serious side effects, although these are rare. Some of the symptoms you should be aware of include:
- Agitation or paranoia
- Allergic reactions such as hives; difficulty breathing; swelling of your face, lips, tongue or throat
- Vision changes including blurred vision and difficulties focusing
- Rapid heartbeat (tachycardia), chest pain or shortness of breath which could indicate cardiovascular issues
- Lowered blood sodium levels - this can result in headache, confusion, slurred speech, severe weakness and unsteadiness
- Neurological reaction - rigidity in muscles accompanied by fever and confusion is a sign to contact your doctor immediately.
Serotonin syndrome is extremely rare when taking Daytrana but if you experience symptoms such as hallucinations, fever sweating shivering fast heart rate muscle stiffness twitching loss of coordination nausea vomiting diarrhea seek immediate medical attention.
What are the most common side effects for Adderall?
Adderall, similar to Daytrana, can have side effects but they may manifest differently. These are some common ones:
- Dry mouth and unpleasant taste in the mouth
- Nervousness or restlessness
- Difficulty sleeping (insomnia)
- Stomach pain or nausea
- Weight loss due to decreased appetite
- Increased heart rate
- Headache or dizziness
- Shortness of breath
- Unusual sweating and feeling hot.
Remember that while these side effects might sound concerning, not everyone experiences them and when they do occur, it's usually at the beginning of treatment while your body is getting used to the medication. Always consult with a healthcare professional if you experience any discomfort while taking Adderall.
Are there any potential serious side effects for Adderall?
Adderall, while being a highly effective medication for conditions such as ADHD and narcolepsy, can occasionally have serious side effects. Symptoms that may indicate a potentially severe reaction to Adderall include:
- Signs of allergic reactions: hives; difficulty breathing; swelling of your face, lips, tongue or throat
- Mood swings or behavior changes: aggression, hostility, paranoia
- Heart problems: chest pain, trouble breathing, feeling like you might pass out
- Increased blood pressure: severe headaches blurred vision; pounding in your neck or ears
- Neurological symptoms: unexplained wounds on your fingers or toes (Raynaud's phenomenon)
If you experience any of these symptoms after taking Adderall it is important to seek medical attention immediately.
Contraindications for Daytrana and Adderall?
Both Daytrana and Adderall, along with most other medications for ADHD, may worsen symptoms of anxiety or agitation in some people. If you notice your anxiety intensifying or feelings of restlessness increasing after starting either medication, please seek immediate medical attention.
Neither Daytrana nor Adderall can be taken if you are taking, or have recently been taking monoamine oxidase (MAO) inhibitors. Always inform your doctor about all the medications you are currently using; MAOIs require a period of approximately 2 weeks to clear from the body to prevent dangerous interactions with both Daytrana and Adderall.
How much do Daytrana and Adderall cost?
For the brand name versions of these drugs:
- A one-month supply (30 patches) of Daytrana (20 mg) averages around $370, which works out to about $12.33/day.
- The price for 60 tablets of Adderall XR (20 mg) is approximately $400, equating to roughly $6.67/day.
Thus, if you use one patch or tablet a day as often prescribed, then brand-name Adderall is less expensive on a per-day treatment basis. However, cost should not be the primary consideration when determining which of these medications is right for you.
As for their generic counterparts:
- Methylphenidate transdermal system (the active ingredient in Daytrana), unfortunately does not have a widely available generic version at present.
- Amphetamine salts ER (the equivalent to Adderall XR) is available in pack sizes ranging from 100 capsules and upward with prices starting as low as about $0.50/day depending on your dosage and where it's purchased. It's important to note that costs can vary depending upon location and individual insurance coverage plans.
Popularity of Daytrana and Adderall
Methylphenidate, in its transdermal patch form known as Daytrana, was estimated to have been prescribed to about 1.2 million people in the US in 2020. Methylphenidate accounted for just over 9% of ADHD prescriptions in the US. However, it stands out due to its unique delivery method; Daytrana is the only ADHD medication available as a skin patch and has been generally increasing in prevalence since its approval by FDA.
Amphetamine mixed salts, including brand versions such as Adderall, were prescribed to approximately 17 million people in the USA during 2020. In terms of stimulant prescriptions for ADHD treatment within this same timeframe, amphetamines account for nearly half (48%). The use of Adderall has also steadily increased over recent years primarily driven by an increase in diagnosed cases of adult ADHD.
Conclusion
Both Daytrana (methylphenidate patch) and Adderall (amphetamine salts) have a history of effectiveness in treating patients with Attention Deficit Hyperactivity Disorder (ADHD), as demonstrated by numerous clinical studies. Both medications work by increasing the concentration of certain neurotransmitters in the brain that play key roles in cognition and attention. Daytrana primarily increases dopamine levels, while Adderall boosts both dopamine and norepinephrine.
In some cases, these drugs may be used together under careful supervision from a healthcare professional, though they can also interact negatively with each other due to their similar mechanisms of action.
Daytrana is unique in being a transdermal patch which provides continuous medication release throughout the day once applied on the skin, whereas Adderall is taken orally usually one to three times per day depending on individual needs.
Both medications are available as generic versions providing cost-efficiency for out-of-pocket payers. They may require an adjustment period when starting or changing doses, meaning immediate effects might not always be noticeable.
The side effect profiles are comparable between both treatments; however, since they stimulate central nervous system activity, possible side effects include insomnia, decreased appetite and mood changes among others. Importantly for individuals using either drug - especially children - moods should be closely monitored at all times during treatment. If symptoms like worsening behavior or thought patterns occur or if suicidal ideation surfaces medical help should be sought immediately.
Other Trials to Consider
Popular Categories
Popular Guides
Learn More About These Treatments
Refrences
- Anderson, V. R., & Scott, L. J. (2006). Methylphenidate Transdermal System. Drugs. Springer Science and Business Media LLC.http://doi.org/10.2165/00003495-200666080-00007
- Fitzgerald, K. T., & Bronstein, A. C. (2013, February). Adderall® (Amphetamine-Dextroamphetamine) Toxicity. Topics in Companion Animal Medicine. Elsevier BV.http://doi.org/10.1053/j.tcam.2013.03.002
- Ahmann, P. A., Theye, F. W., Berg, R., Linquist, A. J., Van Erem, A. J., & Campbell, L. R. (2001, January 1). Placebo-Controlled Evaluation of Amphetamine Mixture—Dextroamphetamine Salts and Amphetamine Salts (Adderall): Efficacy Rate and Side Effects. Pediatrics. American Academy of Pediatrics (AAP).http://doi.org/10.1542/peds.107.1.e10
- WILENS, T. E., BOELLNER, S. W., LÓPEZ, F. A., TURNBOW, J. M., WIGAL, S. B., CHILDRESS, A. C., … MANOS, M. J. (2008, June). Varying the Wear Time of the Methylphenidate Transdermal System in Children With Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. Elsevier BV.http://doi.org/10.1097/chi.0b013e31816bffdf